NewsBenzingaStandard BioTools、以前発表していたMass Cytometry事業をMultiplex Bioに売却する契約を終了。代わりに、Mass Cytometry事業をElement Biosystemsへ550万ドルの現金で売却する最終契約を締結。 Standard BioTools、以前発表していたMass Cytometry事業をMultiplex Bioに売却する契約を終了。代わりに、Mass Cytometry事業をElement Biosystemsへ550万ドルの現金で売却する最終契約を締結。 Benzinga 2026.09.30 20:45 (GMT+0) Open on Benzinga Other news 2026 Financial Street Forum Annual Conference opens this afternoon; heads of four departments including Pan Gongsheng and Wu Qing to deliver keynote speeches Bithumb to suspend BLAST withdrawals on Oct 19 to support network migration to Ethereum Apple plans to release new products on four consecutive Fridays Gate Launches CLAUDIA Contracts, Trading Bots and Copy Trading Key News from Last Night and This Morning (October 18–19) Palantir Stock: AI In Production While Everyone Else Is Still Piloting (NASDAQ:PLTR)
2026 Financial Street Forum Annual Conference opens this afternoon; heads of four departments including Pan Gongsheng and Wu Qing to deliver keynote speeches
